Empagliflozin and linagliptin and SPB11
Determining the interaction of Empagliflozin and linagliptin and SPB11 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium phenylbutyrate, Sodium Phenylbutyrate Powder
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Specimen Collection Kit
- Empagliflozin and linagliptin-Spectazole
- Empagliflozin and linagliptin-Spectazole Topical
- Empagliflozin and linagliptin-Spectracef
- Empagliflozin and linagliptin-Spectro Tar Skin Wash Topical
- Empagliflozin and linagliptin-Spiriva
- SPB11-Empagliflozin and metformin
- SPB11-Empagliflozin and Metformin Extended-Release Tablets
- SPB11-Empagliflozin and Metformin Tablets
- SPB11-Empliciti
- SPB11-Emsam
- SPB11-Emsam Transdermal